Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants ; volume:8 ; number:1 ; day:20 ; month:11 ; year:2023 ; pages:1-5 ; date:12.2023
npj vaccines ; 8, Heft 1 (20.11.2023), 1-5, 12.2023
- Urheber
-
Ong, Chon Phin
Tang, Kaiming
Cheung, Pak-Hin Hinson
Zhang, Hongzhuo
Tang, Tze-Tung
Xue, Yaqian
Wang, Junjue
To, Kelvin Kai-Wang
Yuan, Shuofeng
Ye, Zi-Wei
Jin, Dong-Yan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00776-x
- URN
-
urn:nbn:de:101:1-2024020710311699433638
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ong, Chon Phin
- Tang, Kaiming
- Cheung, Pak-Hin Hinson
- Zhang, Hongzhuo
- Tang, Tze-Tung
- Xue, Yaqian
- Wang, Junjue
- To, Kelvin Kai-Wang
- Yuan, Shuofeng
- Ye, Zi-Wei
- Jin, Dong-Yan
- SpringerLink (Online service)
Ähnliche Objekte (12)
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Technetium abundance in Omicron Ceti
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China